xemebiopharma.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.xemebiopharma.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change
Meta Tags
Title XEME
Description top of page Home Management Mircea Popescu Richard Robb Dr. Vargas Historical Perspective Proposed Mechanism of Action Experimental & Clinical Evidence Wh
Keywords N/A
Server Information
WebSite xemebiopharma faviconxemebiopharma.com
Host IP 185.230.63.186
Location -
Related Websites
Site Rank
More to Explore
xemebiopharma.com Valuation
US$6,645,931
Last updated: 2023-05-01 02:38:50

xemebiopharma.com has Semrush global rank of 1,592,599. xemebiopharma.com has an estimated worth of US$ 6,645,931, based on its estimated Ads revenue. xemebiopharma.com receives approximately 766,839 unique visitors each day. Its web server is located in -, with IP address 185.230.63.186. According to SiteAdvisor, xemebiopharma.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$6,645,931
Daily Ads Revenue US$6,135
Monthly Ads Revenue US$184,042
Yearly Ads Revenue US$2,208,494
Daily Unique Visitors 51,123
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
xemebiopharma.com. A 3599 IP: 185.230.63.186
xemebiopharma.com. A 3599 IP: 185.230.63.171
xemebiopharma.com. A 3599 IP: 185.230.63.107
xemebiopharma.com. NS 86400 NS Record: ns14.wixdns.net.
xemebiopharma.com. NS 86400 NS Record: ns15.wixdns.net.
xemebiopharma.com. MX 3600 MX Record: 10 mx1.netsolmail.net.
HtmlToTextCheckTime:2023-05-01 02:38:50
top of page Home Management Mircea Popescu Richard Robb Dr. Vargas Historical Perspective Proposed Mechanism of Action Experimental & Clinical Evidence Why XEME’s Vaccines? Personalized Vaccines Non-Personalized, Active Immunotherapy Chronic Lymphocytic Leukemia Non-Hodgkin’s Lymphoma Publications Investor Information Contact for Investment Contact XEME Biopharma Inc. Innovative Therapeutic Cancer Vaccines Technology Product Pipeline Investor Information At present, XEME Biopharma is focused on two integrated technology platforms: Aggregon® and Oncolipin. The Aggregon® technology is used by the company in the manufacture of Oncoquest™-CLL and Oncoquest™-L, two innovative lead products of personalized (autologous) cancer vaccines for the treatment of leukemia and lymphoma, respectively. XEME Investor Information ​ Read More Our clinical-stage Company is focused on developing therapeutic products under the guidance of the Food and Drug Administration (FDA) in the area of active cancer
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Sat, 23 Oct 2021 18:13:24 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.xemebiopharma.com/
strict-transport-security: max-age=120
x-wix-request-id: 1635012804.3843009255972920287
Age: 0
Server-Timing: cache;desc=miss, varnish;desc=miss, dc;desc=42
X-Seen-By: jeslxIFvDH4ulYwNNi+3Muwfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVi+P0yj8Af8/paqX0JLrR68,m0j2EEknGIVUW/liY8BLLl3+z1LPCVX20aGaUcDWZPwcm7On4dir39PTYYK13tG9,2d58ifebGbosy5xc+FRalggLSnCzT1b6YVoH1xR/MfiWYZqUM0+4ZLy4H/RfkKeZGdwRNHgkAQ7HxuvzgGping==,2UNV7KOq4oGjA5+PKsX47HYXd6zDG0Q4ZvIB35CKuI8fbJaKSXYQ/lskq2jK6SGP,YO37Gu9ywAGROWP0rn2IfgW5PRv7IKD225xALAZbAmk=,qQbTLsvPZVUXp9HeAm/lzHIofvEQzUzZmzLcBTvjkLhGp/J3MBzgzU8QHrQuh4zQ,UvY1uiXtmgas6aI2l+unv1Al4yzjdsCz2EPadF7XOE9eTwBpBkrHI3CVgJV25hLEvGQ2Otd3B2C27oTTIAKJtQ==
Cache-Control: no-cache
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Sat, 23 Oct 2021 18:13:24 GMT
content-type: text/html; charset=UTF-8
content-length: 392719
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
etag: W/"135f907b09ac60964f6fc62525549bd2"
content-language: en
strict-transport-security: max-age=120
age: 60290
set-cookie: ssr-caching=cache#desc=hit#varnish=hit#dc#desc=42; Max-Age=20; Expires=Sat, 23 Oct 2021 01:28:54 GMT
server-timing: cache;desc=hit, varnish;desc=hit, dc;desc=42
x-seen-by: wmgbEcS9zOENaefw7bU4YbwbN7cH/0r/4Qxj9cyhfv8=,6ivkWfREES4Y8b2pOpzk7Owfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVi+P0yj8Af8/paqX0JLrR68,m0j2EEknGIVUW/liY8BLLsk16xozuw6nSXf6CEzK6Aca0sM5c8dDUFHeNaFq0qDu,2d58ifebGbosy5xc+FRalvIP6sOVZraqlBjSeYOYaMhxeaZM/xm7OlFOkq9iOn/lusCem2qDW2ksmmawi3xOGw==,2UNV7KOq4oGjA5+PKsX47DqQgZ4euQCNWDy58PBtjlYfbJaKSXYQ/lskq2jK6SGP
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
x-wix-request-id: 1635012804.5913005093633426407
x-content-type-options: nosniff
set-cookie: TS01e85bed=01f0e93131f85a13d39abcdfd0266c0bf621cb44b30aa610b1bf2426e02f1bcebb6168c1381dcc79847afbd908c7f8144555aabbd7; Path=/;SameSite=none;Secure
server: Pepyaka/1.15.10
xemebiopharma.com Whois Information
Domain Name: XEMEBIOPHARMA.COM
Registry Domain ID: 213822739_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2021-07-23T08:29:30Z
Creation Date: 2005-09-21T17:03:24Z
Registry Expiry Date: 2023-09-21T17:03:24Z
Registrar: Network Solutions, LLC
Registrar IANA ID: 2
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS14.WIXDNS.NET
Name Server: NS15.WIXDNS.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-12T04:12:50Z <<<

Copyright © 2022 WebZZ.US 0.0302